The Hastings Center: Should we enroll our child in a COVID-19 vaccine trial?
UC professor and Cincinnati Children's ethicist tackles a weighty topic as the pandemic continues
Elizabeth Lanphier, PhD, an assistant professor in the UC Department of Pediatrics, is also a clinical ethics at Cincinnati Children’s Hospital Medical Center. As part of an opinion piece Lanphier discusses her own family’s choices in deciding whether to enroll a child in Pfizer’s clinical trial which is recruiting 5-to-11 year olds.
Elizabeth Lanphier, PhD.
“As a clinical ethicist I am engaged in weighing risks and benefits of medical decisions,” writes Lanphier. “Yet when it comes to doing this for my child and family, it’s complicated. Risks and benefits of Covid-19 vaccine trials are multi-faced, sometimes uncertain, and difficult to quantify.
Let’s start with what is clear. In my family, the benefits of Covid-19 vaccination far outweigh the known risks. My spouse and I were vaccinated when eligible.”
Read the full opinion piece penned by Elizabeth Lanphier, PhD, online.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.